DEXCOM, INC.

DexCom, Inc. specializes in the manufacturing of in vitro diagnostic substances, including reagents, test kits, and test sets designed for clinical and point-of-care use. Their technical expertise lies in developing precision diagnostic systems that enable continuous monitoring of physiological biomarkers, particularly in chronic disease management. The company’s capabilities center on proprietary biosensor technology, analytical chemistry, and regulatory-compliant production of diagnostic consumables, ensuring reliability and accuracy in patient-facing medical devices. Key differentiators include integrated software-hardware platforms, closed-loop system design, and adherence to stringent FDA and CLIA standards for diagnostic product development and quality control. DexCom has delivered diagnostic solutions to the Department of Veterans Affairs, providing critical testing infrastructure for veteran healthcare programs. Their engagement with VA reflects a focus on supporting chronic condition management—such as diabetes monitoring—through scalable, clinically validated diagnostic kits deployed in VA medical centers and outpatient clinics. This relationship underscores a pattern of supplying mission-critical, high-volume diagnostic consumables aligned with VA’s long-term care and telehealth initiatives. The company’s primary industry focus is in in vitro diagnostic substance manufacturing, a niche requiring rigorous validation of analytical performance, shelf-life stability, and batch-to-batch consistency. DexCom positions itself as a specialized provider of diagnostic reagents and test systems tailored for continuous glucose monitoring and related applications, serving the broader medical device and clinical diagnostics market with a focus on patient-centric, real-time health data capture. DexCom, Inc. is a commercial entity structured as a 2L corporation headquartered in San Diego, California. While no federal certifications are listed, the company operates under FDA-regulated quality systems and maintains compliance with ISO 13485 for medical device manufacturing. Their geographic presence is anchored in California, with a market position centered on supplying advanced diagnostic technologies to federal healthcare systems requiring high-accuracy, FDA-cleared test platforms.